TME PHARMA NV (ALTME.PA)
NL0015000YE1 - Common Stock
| MRQ (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 2.70M | 2.25M | 4.63M | 9.46M | 10.30M | |||
| Marketable Securities | 4.00K | N/A | 0.00 | 30.00K | 30.00K | |||
| Receivables | N/A | 41.00K | 279.00K | 80.00K | 70.00K | |||
| Inventories | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 192.00K | 100.00K | 98.00K | 130.00K | 120.00K | |||
| Total Current Assets | 2.90M | 2.39M | 5.01M | 9.69M | 10.53M | |||
| Non-Current Assets | ||||||||
| PPE Net | 34.00K | 96.00K | 221.00K | 70.00K | 120.00K | |||
| Investments And Advances | 5.00K | 5.00K | 5.00K | 10.00K | 10.00K | |||
| Intangibles | 4.00K | 4.00K | 4.00K | 0.00 | 0.00 | |||
| Other Non-Current Assets | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 43.00K | 105.00K | 230.00K | 80.00K | 120.00K | |||
| TOTAL ASSETS | 2.94M | 2.49M | 5.24M | 9.77M | 10.65M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 5.00K | 66.00K | 112.00K | 20.00K | 50.00K | |||
| Accrued Expenses | N/A | 334.00K | 482.00K | 480.00K | 430.00K | |||
| Accounts Payable | 1.04M | 1.17M | 1.70M | 2.24M | 1.80M | |||
| Other Current Liabilities | 331.00K | 1.22M | 4.16M | 2.53M | 620.00K | |||
| Total Current Liabilities | 1.38M | 2.79M | 6.45M | 5.27M | 2.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 67.00K | 0.00 | 60.00K | |||
| Other Non-Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 67.00K | -20.00K | 40.00K | |||
| TOTAL LIABILITIES | 1.38M | 2.79M | 6.51M | 5.25M | 2.94M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -197.62M | -194.37M | -187.63M | -172.50M | -158.05M | |||
| Additional Paid In Capital | 198.98M | 194.12M | 184.84M | 176.46M | 165.48M | |||
| Minority Interest | N/A | N/A | 0.00 | -10.00K | -10.00K | |||
| Common Shares | 422.00K | 173.00K | 1.74M | 750.00K | 470.00K | |||
| Treasury Stock | -227.00K | -224.00K | -223.00K | -190.00K | -190.00K | |||
| Other Shareholders' Equity | 9.00K | 6.00K | 8.00K | 10.00K | N/A | |||
| Shares Outstanding | 42.12M | 17.28M | 1.72M | 750.00K | 470.00K | |||
| Tangible Book Value per Share | 0.04 | -0.02 | -0.74 | 6.01 | 16.40 | |||
| Total Shareholders' Equity | 1.57M | -294.00K | -1.27M | 4.52M | 7.71M | |||
| TOTAL LIABILITIES AND EQUITY | 2.94M | 2.49M | 5.24M | 9.77M | 10.65M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | -0.05 | N/A | 0.01 | |||
| Current Ratio | 2.11 | 0.86 | 0.78 | 1.84 | 3.63 | |||
| Return On Assets (ROA) | -214.99% | -270.41% | -288.72% | -147.90% | -97.75% | |||
| Return On Equity (ROE) | -403.64% | N/A | N/A | -319.69% | -135.02% | |||
All data in EUR , ROIC based on taxRate of 0.27